Halozyme Therapeutics Inc (HALO)

[maumar]

Or maybe not! We did get a downgrade from Barclays a few days ago but this kind of volatility strikes me as odd. On the other hand, I guess one large fund buying or selling is all it takes.

I don't see compelling reasons to add but also no reason to sell, though I suspect royalty revenue growth will not be very strong in the next 12/18 months and it may be another year before we get PEGPH20 results.